Acute and Sub‐Acute Toxicity Assessment of Cardionogen‐1 in C57BL/6J Mice
Journal of Applied Toxicology · 2025
DOI: 10.1002/jat.4984 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Toxicology, 2025. Verfasst von Karthik Shree Harini und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, India. Die Arbeit nennt 25 Literaturangaben. Gefördert von: Indian Council of Medical Research.
Abstract (Originalsprache)
Cardionogen‐1 (CDNG‐1), a small molecule inhibitor of Wnt/β‐catenin signaling, has shown promising pharmacological effects, in vitro but its in vivo safety remains unclear. This study assessed both acute and sub‐acute toxicity of CDNG‐1 in C57BL/6J mice of both sexes. For acute toxicity testing, the mice were intraperitoneally (i.p.) administered with a single dose of 5, 50, 300, or 2000 μM/kg body weight (b.w.) CDNG‐1 and observed for 14 days. In the sub‐acute study, mice were treated with 250, 500, or 1000 μM/kg b.w., i.p., CDNG‐1 once daily for 28 days. The animals were monitored for toxic signs and mortality throughout the experiment. Various biochemical and hematological parameters were analyzed along with histopathological examination. The acute toxicity study showed that the LD 50 value of CDNG‐1 is more than 2000 μM/kg. In both the acute and sub‐acute toxicity studies, the male and female mice showed no clinical signs of toxicity or death. Body weight changes and vital organ weights of the CDNG‐1–treated mice remained comparable to control. Hematological and biochemical parameters, including liver and kidney markers, showed no significant alterations. Although a significant change in the hemoglobin level was observed in female mice treated with 250 and 500 μM/kg b.w., CDNG‐1 for 28 days, it was within the normal range and not considered toxic. Gross morphological analysis and histopathological examination of the liver, kidney, and heart further revealed intact tissue architecture without marked pathology. Therefore, these findings suggest that CDNG‐1 is well tolerated and did not induce any adverse effects in C57BL/6J adult male and female mice under both acute and repeated‐dose exposure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, India.
ORCID-Profile: Devaraj Ezhilarasan, Munusamy Karthick
Förderung
- Indian Council of Medical Research
Zitieren
APA
Shree Harini, K., Ezhilarasan, D., Karthick, M., Sharmila, M., Sanjay, S., & Anitha, R. (2025). Acute and Sub‐Acute Toxicity Assessment of Cardionogen‐1 in C57BL/6J Mice. Journal of Applied Toxicology. https://doi.org/10.1002/jat.4984
Vancouver
Shree Harini K, Ezhilarasan D, Karthick M, Sharmila M, Sanjay S, Anitha R. Acute and Sub‐Acute Toxicity Assessment of Cardionogen‐1 in C57BL/6J Mice. Journal of Applied Toxicology. 2025. doi:10.1002/jat.4984
BibTeX
@article{ShreeHarini2025,
author = {Shree Harini, Karthik and Ezhilarasan, Devaraj and Karthick, Munusamy and Sharmila, Muthusethupathi and Sanjay, Somasundaram and Anitha, Roy},
title = {Acute and Sub‐Acute Toxicity Assessment of Cardionogen‐1 in C57BL/6J Mice},
journal = {Journal of Applied Toxicology},
year = {2025},
doi = {10.1002/jat.4984}
}
EUVIMED